Cargando…

Dalbavancin

Dalbavancin is a long-acting antimicrobial agent with an excellent in vitro activity against Gram-positive pathogens, including staphylococcal biofilms. The unusually long terminal half-life ranging from 149 to 250 hours in human subjects, allows a weekly dose. Currently is indicated in acute bacter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barberán, José, de la Cuerda, Alicia, Barberán, Lourdes Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedad Española de Quimioterapia 2021
Materias:	Update on Antimicrobial Pharmacotherapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683005/ https://www.ncbi.nlm.nih.gov/pubmed/34598419 http://dx.doi.org/10.37201/req/s01.07.2021

Ejemplares similares

Ceftazidime-avibactam
por: Matesanz, Mayra, et al.
Publicado: (2021)

Cefiderocol, a new antibiotic against multidrug-resistant Gram-negative bacteria
por: Silva, José Tiago, et al.
Publicado: (2021)

Ceftolozane-tazobactam: When, how and why using it?
por: López, Inmaculada, et al.
Publicado: (2021)

Ceftobiprole: a clinical view
por: Pérez-Crespo, Pedro María Martínez, et al.
Publicado: (2021)

Tedizolid: new data and experiences for clinical practice
por: Lletí, Miguel Salavert, et al.
Publicado: (2021)

Ceftaroline
por: Soriano, Alex
Publicado: (2021)

Antithrombotic Treatment After Coronary Intervention: Agreement and Controversy
por: Camarero, Tamara García, et al.
Publicado: (2020)

Seguridad en la selección del tratamiento antibiótico oral en las infecciones comunitarias, más allá de la COVID-19
por: Barberán, José, et al.
Publicado: (2021)

Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Target Attainment Analyses for Dalbavancin in Pediatric Patients
por: Carrothers, Timothy J., et al.
Publicado: (2022)

AF in Cancer Patients: A Different Need for Anticoagulation?
por: Sanz, Ana Pardo, et al.
Publicado: (2019)

Antithrombotic Therapy After Transcatheter Aortic Valve Implantation
por: Lugo, Leslie Marisol, et al.
Publicado: (2020)

Effect of the new 75-mg orodispersible film of sildenafil on erection and sexual quality of life: insights from an observational study
por: Sansone, Andrea, et al.
Publicado: (2023)

The Safety and Efficacy of Dalbavancin and Active Comparator in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infections
por: Giorgobiani, Manana, et al.
Publicado: (2022)

The Effect of Food on the Pharmacokinetics of Buspirone After Single Administration of a Sublingual Testosterone and Oral Buspirone Combination Tablet in Healthy Female Subjects
por: Gerritsen, Jeroen, et al.
Publicado: (2020)

A Practical Guide for Cardiologists to the Pharmacological Treatment of Patients with Type 2 Diabetes and Cardiovascular Disease
por: Ahmad, Tariq, et al.
Publicado: (2021)

Effectiveness of Omalizumab in Severe Allergic Asthma: A Retrospective UK Real-World Study
por: Barnes, Neil, et al.
Publicado: (2013)

Twelve- and 52-week safety of albuterol multidose dry powder inhaler in patients with persistent asthma
por: Raphael, Gordon, et al.
Publicado: (2016)

Early Australian experience in the maintenance of schizophrenia management with 3-monthly paliperidone palmitate
por: Pai, Nagesh, et al.
Publicado: (2018)

Endothelial Dysfunction in Patients With Erectile Dysfunction: A Double-Blind, Randomized-Control Trial Using Tadalafil
por: Pattanaik, Smita, et al.
Publicado: (2019)

Cardiovascular Imaging and Theranostics in Cardiovascular Pharmacotherapy
por: Cattaneo, Mattia, et al.
Publicado: (2019)

Recent Warnings about Antihypertensive Drugs and Cancer Risk: Where Do They Come From?
por: Battistoni, Allegra, et al.
Publicado: (2020)

Safety and Tolerability of Evening Ethanol Consumption and Bedtime Administration of Flibanserin in Healthy Premenopausal Female Subjects
por: Millheiser, Leah, et al.
Publicado: (2019)

Testosterone Management in Aging Males: Surveying Clinical Practices of Urologists and Endocrinologists in Israel
por: Ishay, Avraham, et al.
Publicado: (2019)

Will Direct Oral Anticoagulants Have a Chance in Prosthetic Valves?
por: Abdelnabi, Mahmoud, et al.
Publicado: (2020)

The Daily Therapy With L-Arginine 2,500 mg and Tadalafil 5 mg in Combination and in Monotherapy for the Treatment of Erectile Dysfunction: A Prospective, Randomized Multicentre Study
por: Gallo, Luigi, et al.
Publicado: (2020)

Effect of Icariside II and Metformin on Penile Erectile Function, Histological Structure, Mitochondrial Autophagy, Glucose-Lipid Metabolism, Angiotensin II and Sex Hormone in Type 2 Diabetic Rats With Erectile Dysfunction
por: Zhang, Jian, et al.
Publicado: (2020)

D-53 | Impact of Cardiovascular Diseases, Calcium Channel Blockers and Beta-Blockers on Mortality of Patients Hospitalized with COVID-19
por: Alhusain, Rashid, et al.
Publicado: (2022)

Efficacy and safety outcomes of a compounded testosterone pellet versus a branded testosterone pellet in men with testosterone deficiency: a single-center, open-label, randomized trial
por: Kresch, Eliyahu, et al.
Publicado: (2023)

STOMp: sexual function trial of overactive bladder medication
por: Polland, Allison, et al.
Publicado: (2023)

The availability of gonadotropin therapy from FDA-approved pharmacies for men with hypogonadism and infertility
por: Borgert, Benjamin J, et al.
Publicado: (2023)

Perspectives and Future Directions of Anticoagulant Therapy in Coronary Artery Disease Patients
por: Komiyama, Maki, et al.
Publicado: (2023)

Nuclear Factor-κB is a Prime Candidate for the Diagnosis and Control of Inflammatory Cardiovascular Disease
por: Matsumori, Akira
Publicado: (2023)

Carotid artery intima media thickness can predict the response to phosphodiesterase 5 inhibitors in patients with moderate erectile dysfunction
por: Kilic, Metin, et al.
Publicado: (2023)

Validating the Prognostic Utility of the ABCD-GENE Score in Asian Patients with Acute Coronary Syndrome Patients on Clopidogrel
por: Tan, Cheng Keat, et al.
Publicado: (2023)

Safety profile and signal detection of phosphodiesterase type 5 inhibitors for erectile dysfunction: a Food and Drug Administration Adverse Event Reporting System analysis
por: Shin, Young Eun, et al.
Publicado: (2023)

The hidden cost of dalbavancin: OPAT RN time required in coordination for persons who use drugs
por: Douglass, Alyse H., et al.
Publicado: (2023)

Controversies in the management of ESBL-producing Enterabacterales. Clinical Implications
por: Maseda, Emilio, et al.
Publicado: (2022)

The incretin/glucagon system as a target for pharmacotherapy of obesity
por: Del Prato, Stefano, et al.
Publicado: (2021)

Review of pharmacotherapy for smoking cessation in patients with schizophrenia
por: Shawen, Avery E., et al.
Publicado: (2018)

Cardiovascular Pharmacotherapy Focus
por: Avanzas, Pablo
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1gteench355ec464ve34lnlo0i